Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Actinium Pharmaceuticals, Inc. (ATNM)

The fierce battle for patents in the radioimmunotherapy niche creates significant barriers, yet the aggressive hiring of top specialists strengthens the human capital potential of Actinium Pharmaceuticals (ATNM). The consolidated EBITDA metric helps assess this trend, where the 10.72 level reflects the state of the operating profit parameter. Consequently, unique drugs for bone marrow transplant preparation provide the company with sustainable demand and high margins.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Actinium Pharmaceuticals, Inc. (ATNM): kanggo periode 23.11.2025 - 15.11.2026

Actinium Pharma (ATNM) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Bagan rega actiniumpharma.com|ATNM - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Actinium Pharma|ATNM - Nilai Total Perusahaan

- rincian valuasi buku bisnis:

Nilai Aset Bersih saben Saham Actinium Pharmaceuticals|ATNM - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku actiniumpharma.com|ATNM - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Actinium Pharmaceuticals|ATNM - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Actinium Pharmaceuticals Inc|ATNM - Gunggung utang perusahaan|Utang marang nilai buku Actinium Pharmaceuticals Inc|ATNM - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Actinium Pharmaceuticals|Koefisien jangkoan perantara actiniumpharma.com

- rincian bathi lan kelipatan pasar:

ATNM - Bathi resik perusahaan|Prakiraan bathi resik Actinium Pharmaceuticals|ATNM - Pangali P/E|Kapitalisasi marang proyeksi bathi Actinium Pharmaceuticals Inc|ATNM - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Actinium Pharma|ATNM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Actinium Pharmaceuticals|ATNM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan actiniumpharma.com|ATNM - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Actinium Pharmaceuticals

- data dodolan lan asil:

ATNM - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Actinium Pharmaceuticals|ATNM - Multiplikator P/S|Multiplikator Forward P/S Actinium Pharma|ATNM - Wutah dodolan YoY sajrone rolas wulan kepungkur

Ringkesan analitik perusahaan:ATNM - Actinium Pharmaceuticals, Inc.

Barang unggulan Actinium Pharmaceuticals, Inc.

This metric is calculated as operating income excluding depreciation and taxes, measuring the actual cash flow from core operations to assess the business's financial stability. In the context of Actinium Pharmaceuticals (ATNM), the EBITDA_Co indicator on the GURU.Markets platform reflects the efficiency of implementing robotic drug synthesis, where process automation minimizes manual labor costs, determining the company's long-term ability to maintain revenue plateaus.

Analisis pesaing Actinium Pharmaceuticals